Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Imatinib cost effective for GIST in the US

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Imatinib cost effective for GIST in the US. Pharmacoecon. Outcomes News 486, 7 (2005). https://doi.org/10.2165/00151234-200504860-00014

    Download citation

    Keywords

    • Health Outcome
    • Life Expectancy
    • Imatinib
    • Diagnostic Test
    • Palliative Care